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There is a similarity in the approach taken by Dr. Wolf (Dr.
Stewart G .,- the 1967 Stoneburner
Lecturer) and Col. Moser to the
one I will present to you. Dr. Wolf
is interested in why some people
die suddenly and why others do
not. What are the factors responsible for predisposition? The major
theme of our studies on the epidemiology of adverse drug reactions has been to gain understanding of why some people will have
trouble and others will not when
given the same drugs in essentially
the same way and for the same reasons. Col. Moser spoke to the
problem of adverse drug reactions,
i.e., their recognition, identification, and documentation. Epidemiological methods allow us to identify reactions, when they occur,
and to establish the risk involved
in administration of drugs to patients.
In any epidemiological study
there are two pieces of information
that must be accumulated. One is
denominator data and the other is
numerator data. When we began
our studies about five years ago,
our initial attention was directed
toward assembling denominator
data. How many drugs are used?
What patients receive them? Under
what circumstances? These data
identified the population at risk.
One should also know the dosage
form in which the drug is administered, and have information on
the duration of therapy. Unfortunately, the latter two pieces of
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information are difficult to obtain,
because, as Col. Moser has pointed
out, the accumulation of masses of
information on patients at risk and
the drugs they receive is an overwhelming task requiring automatic
data processing. At present, in
most hospitals, it is impossible to
retrieve information on dosage
form or duration of therapy, although in most instances it is possible to identify the population at
risk receiving given groups of
drugs.
Drug Usage in Hospitals
I will summarize some of the
pertinent observations that we have
made during the course of our investigations.
The most frequently used drugs
in a hospital, as you might expect,
are tranquilizers and sedatives. It
is interesting, however, in reference to Col. Moser's paying particular attention to tetracycline, that
in one survey at the Johns Hopkins
Hospital, five of the ten most commonly prescribed drugs were antimicrobial agents.
The studies that I will speak
about were confined largely to an
evaluation of drug usage and adverse reactions to drugs on a medical service at the Johns Hopkins
Hospital. This included an evaluation of private and public patients.
The results were in essence identical, so there is no point in differentiating them.
On the medical service at the
Johns Hopkins Hospital the aver-

age number of drugs given to a
patient during hospitalization was
11. This ranged from zero to 42
different drugs. We have identified
only one patient who received no
medication during hospitalization.
It is interesting to evaluate the
kinds of drugs patients receive. In
one study, evaluating all the patients in the hospital receiving
methicillin, we identified a patient
who received 37 different drugs,
and this patient received five different antimicrobial agents during
the course of hospitalization. In
other university medical centers,
the average number of drugs administered to patients on medical
services is about 10 to 14 different
medications during hospitalization.
Examining drug usage can be a
useful exercise. It's not just a collection of meaningless data. I
would like to point out one example of how this was important at
Johns Hopkins Hospital.
During the initial phase of our
study on drug usage, we became
aware that the surgical service used
the most chloramphenicol in the
hospital. We investigated the patients on the surgical service who
received chloramphenicol. Most of
the patients received the drug prophylactically, in an attempt to prevent wound infections. But the interesting thing was to determine
why chloramphenicol was being
used as a prophylactic drug, when
this is not considered advisable.
Two years before, one of the surgeons on the staff had done a study
MCV QUARTERLY 3(2): 72·76, 1967

L. E. CLUFF
of the effectiveness of chloramphenicol in prevention of postoperative wound infections. He had
instituted a study with a doubleblind placebo and the housestaff
administered the drugs in random
fashion to the patients on the service, some getting chloramphenicol
and some getting placebo. The
study was conducted for six
months. The surgeon evaluated his
data, found no difference in the
frequency of wound infections, and
terminated his study. By this time,
the surgical staff had become accustomed to using chloramphenicol
prophylactically, however, and the
practice was perpetuated. When
this was brought to the attention
of the surgeon-in-chief, some curtailment in the use of chloramphenicol was possible.
Detection of Adverse Drug
Reactions
Identification of adverse drug reactions, when patients receive 11
different drugs, is a problem. When
a reaction occurs or when some
anticipated illness develops how
can the physician 1) be certain
that it is an adverse reaction to
a drug, and 2) identify the specific
drug responsible for the adverse
effect. When a patient develops a
febrile reaction or granulocytopenia
during hospitalization, and he is
receiving 42 different drugs, you
tell me which one is involved! We
can go to the literature and identify
those drugs incriminated previously,
but we may overlook the one that
is specifically involved.
Methods of Detection
What are some of the methods
that can be employed for detection
of adverse reactions? The AMA
Registry on Drugs and the Food
and Drug Administration are using
voluntary reporting, the system we
initially adopted. In epidemiological studies, however, one needs
a complete numerator and denominator. Otherwise incidence and
rates cannot be accurately deter-

mined. We instituted a voluntary
reporting system throughout the
Johns Hopkms Hospital for one
year. The average number of adverse reactions reported initially
was 15 per month. It gradually
went up to 25 per month at the
end of the year. We thought this
was under-reporting, so an effort
was made to examine the records
of patients upon whom reports had
been obtained, as well as those on
whom reports had not been obtained. Only one-tenth of all significant adverse reactions had been
reported voluntarily. Obviously voluntary reporting is incomplete. Us
greatest usefulness is in the identification of previously unrecognized
ill effects of a drug.
The only way to collect complete data is by personalized surveillance. This can be done, prospectively or retrospectively, and we
have done both. A retrospective
analysis is notoriously inadequate.
To evaluate this we selected the
records of patients who had been
given Warfarin. The ill effects of
anticoagulant drugs are readily
identifiable. In a retrospective
analysis 10% of the patients who
received this anticoagulant drug
had some manifestation of bleeding, gross or microscopic. The
commonest site of bleeding, of
course, was in the urine. Most
commonly the bleeding was microscopic. Occasionally, blood was
found in the feces, but subarachnoid hemorrhage and massive
bleeding into the pleural space following thoracentesis was demonstrable. This method too, however,
was an inadequate way of obtaining data, because doctors are not
good at recording reactions in patients' charts. This is illustrated by
the fact that the majority of the
patients rece1vmg Wafarin had
one urinalysis and had one stool
examination for occult blood done
during hospitalization and that was
the day of admission. Generally
these examinations were not repeated. The necessary tests were
not done to detect the most com-

mon sites of bleeding in patients
receiving anticoagulants.
Personalized prospective surveillance was the only way to obtain
complete information. Three
methods have been evaluated: 1)
surveillance of all patients receiving a particular drug in the hospital; 2) surveillance of all patients
with a particular disease in the
hospital, the drugs they receive,
and the reactions they may develop; 3) surveillance of groups of
patients, such as those on a medical service or surgical service. The
latter is the one that has proven,
in our hands, the most useful in uncovering information relevant to
the factors that predispose patients
to reactions.
Definition of a Reaction
Another problem is the definition of a reaction. It can be defined by mechanism involved, clinical features, or in terms of severity
or probability. Severity is relatively
easy to note: 1) fatal or lifethreatening; 2) requiring an antidote or long hospitalization; and 3)
an annoyance. The real difficulty
is documenting the probability of
a reaction. These are the systems
that we have employed : 1) A documented reaction is one known to
occur, with a clear temporal association with the administration
of the drug; on re-cha11enge the
patient has a recurrence of the reaction; or there is some confirmatory laboratory test establishing
that the drug is incriminated in
the patient's illness. 2) Probable
reactions that have a temporal relationship, are known to occur and
disappear on withdrawal of the
medication. We have ignored other
reactions which are possible, because we cannot in those instances
establish this as an adverse drug
effect.
I would like to show you examples of problems in identifying
drug reactions. A 6-year-old boy
with a tetralogy of Fallot was seen
in the hospital for surgical cor73
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rection of his cardiac defect. He
was put on penicillin and streptomycin prophylactically. Following
operation he developed progressively increasing fever, leukocytosis, mild anemia, weight loss, and
anorexia. He had multiple blood
cultures taken which were negative. He had no splenomegaly, nor
did he have microscopic hematuria or petechiae, but the surgeons
felt that he must have a postcardiotomy infection. The dosages
of the anti-microbial drugs were
increased, and others were added.
The therapy was continued for
seven weeks at which time I was
called in consultation. It was suggested that the patient might have
drug fever. Streptomycin, tetracycline, and erythromycin were
stopped without any termination in
the patient's course. Eight hours
after the penicillin was stopped, the
patient was afebrile and left the
hospital four days later. This boy
had fever as the only manifestation
of the ill effects of a drug, and
this was confused with infection.
A young woman was seen in the
emergency room because of a
streptococcal sore throat. She was
given penicillin. Within 48 hours,
she returned to the emergency
room with a florid confluent erythematous rash, and a diagnosis
of scarlet fever was made. The girl
did not have scarlet fever. Following recovery, after discontinuing
her treatment, she was given penicillin again and had a recurrence
of the reaction. Again identification of a reaction and differentiating it from a naturally occurring
disease complicated the identification of a drug reaction.
Adverse Reactions Occurring
in Hospitals

With this as background, let's
look at the overall problem of adverse drug reactions in the hospital.
On the medical service of the Johns
Hopkins Hospital 5% of all the
patients are admitted to the hospital with an adverse drug reaction.
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Four percent of the patients are
admitted to the medical service,
because of adverse effects of drugs.
Adverse drug reactions as a cause
of hospitalization represent the
seventh most common reason for
admission to the medical service.
Of those patients admitted to the
hospital who have a reaction at the
time of admission, 30% will have
a reaction to another drug during
the course of hospitalization. This
contrasts with an overall rate of reactions to drugs of 10% in all patients on the medical service. This
means that the patient who has
had a reaction to a medication has
a three-fold greater likelihood of
having a reaction to another drug
during the course of hospitalization. This identifies patients with
a pronounced predisposition to the
occurrence of reactions.
A patient with miliary tuberculosis who was comatose when admitted to the hospital, was put on
INH, P ASA, and streptomycin.
During the course of the first five
or six days of hospitalization she
defervesced, and regained consciousness. She developed an exfoliative rash and because of this
it was necessary to stop all of her
medication. At that time her temperature declined and her exfoliative rash disappeared. She still had
her miliary tuberculosis, so she
was put back on INH, but this
time she developed a folicular
rash over the face. An industrious
intern aspirated one of these and
grew a Staphylococcus albus. He
was alarmed that the patient might
be developing staphylococcal sepsis, and gave the patient an injection
of penicillin. She went into anaphylactic shock, requiring hydrocortisone and norepinephrine. All
drugs were again stopped, except
that steroid and digitalis were continued. Again, the patient required
treatment for her tuberculosis.
While on prednisone she was given
a single dose of P ASA and had a
frank chill with a prompt rise in
temperature. Subsequently, she was
given a single dose of streptomy-

cin, and again had a prompt chill
and recurrence of fever. During
the course of these 70 days of hospitalization, this patient had documented reactions, to paraminosalicylic acid, penicillin, streptomycin,
and INH.
I would like to return briefly to
the problem of severity. Not all
reactions to drugs seen in hospitals
are mild. Mild reactions account
for almost half of those observed.
Correspondingly almost half of the
patients had reactions sufficiently
severe to warrant the physician's
giving an antidote, prolong hospitalization or to threaten life.
Seven percent of the patients with
adverse reactions had life-threatening or fatal reactions.
Gastrointestinal rea.c tions to
drugs are particularly common in
women. In a report by Jordan and
Dingle, women with colds also
have an increased frequency of
nausea, vomiting, and diarrhea.
Whether this is a specific effect of
drug reactions or whether it is a
peculiarity of females, I don't
know. Nevertheless, in all of our
subsequent studies we have eliminated the minor gastrointestinal reactions, because we cannot be certain of the relationship to the drug
itself. It should be emphasized,
however, that adverse effects of
drugs frequently mimic natural disease.
Tranquilizers and sedatives rank
far above any other drugs as causes
of ill effects in patients. Antimicrobial and cardiac drugs, however,
are near in importance of ill effects
in hospitalized patients. There is
wide variation in rates of reactions
to different drugs. The range was
from 27% (probenecid) down to
3.1% (mercaptomerin). Col.
Moser made the point that before
the physician can significantly
weigh benefit with risk, he must
have such data as this, citing incidence as well as severity. Unfortunately, such data is usually lacking at the present time. In contrast
to Col. Moser, however, I do not
believe the present systems of the
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AMA Council on Drug and the
Food and Drug Administration will
get us to the point of determining
the exact risk.

Severity of Reactions
Patients do die of drug reactions
in the hospital. During one threemonth period on the medical service of the Johns Hopkins Hospital,
there were five deaths due to drugs
in hospitalized patients. It is possible for the physician to avoid
some of these lethal effects as il1ustrated by these patients. A middle-aged man admitted to the
hospital with chronic pulmonary
disease had a coin lesion in his lung.
During the course of his hospitalization it was decided that he should
be bronchoscoped. The pre-bronchoscopic medications were promazine, pentobarbital, and morphine. This medication was given
and he was taken to the endoscopy
room where he developed respiratory arrest. He was given artificial
respiration and returned to the
ward without bronchoscopy with
the advice of the endoscopist that
the patient should not be bronchoscoped because of the problem of
premedication. Two weeks later
there was a change of physicians
on the ward. They were fully aware
that the patient shouldn't be bronchoscoped, but they needed a study
to identify the nature of his pulmonary disease. A bronchogram
was decided upon. The pre-medications for bronchography were promazine, pentobarbital, and morphine, of which the physicians on
the ward were unaware. The premedication was given, and within
a very short time the man went into
shock, cardiac arrest, respiratory
depression, and died. Another patient was a young woman who during her prepartum period on the
obstetrical service had been found
to have a minor urinary tract infection and was given sulfisoxazole.
Her bacteriuria cleared, but she developed an urticaria! and erythematous rash. A note was written

in the progress notes by the obstetrician that the patient was allergic
to sulfonamides and the drug was
discontinued. Following delivery,
the woman was again found to
have bacteriuria. She was now no
longer an obstetrical patient and
was referred to the medical clinic
for evaluation. The obstetrical records were kept in a different part
of the chart from the medical records. Frequently the internist
doesn't read the obstetrician's
notes. Nevertheless, the internist
recognized the bacteriuria and represcribed sulfisoxazole. Very
shortly thereafter she had gross
hematuria. She was admitted to the
hospital hypertensive, had sulfonamide crystalluria, and died in renal
failure. Autopsy revealed she had
typical sulfonamide crystals in the
tubules of her kidney. She undoubtedly died of sulfonamide-induced allergic vasculitis. This illustrates some of the settings in
which lethal effects of drugs can be
observed and how they can be
avoided.
We have been unable to confirm
any relationship in the patient with
atopy and the subsequent development of allergic or other reactions
to drugs. However, history of an
adverse reaction to any drug is associated with a significant increase
in the frequency of reactions to
other drugs subsequently administered. So there is something peculiar about people who have trouble
with drugs. Whether this is heritable or what the factors are that
are particularly involved remains to
further study.
Number of Drugs Administered
An important factor related to
the occurrence of adverse reactions
to drugs in hospitalized patients is
the number of drugs administered.
When one exceeds a total of six
drugs there is a logarithmic increase in the likelihood of the patient's having an adverse reaction
to at least one drug. Of the patients receiving 16 drugs during

the period of hospitalization, 45%
of them will have an adverse reaction to at least one drug that they
have during the period of hospitalization. If I were to recommend
one thing that would significantly
reduce the problem of the ill effects
of drugs, it would be to curtail the
use of innumerable drugs. This is
undoubtedly the most important
factor we have thus far identified.
Why this curve is logarithmic I
don't know. Our present feelings
are that much of this is a problem
of drug interaction, interactions
that conceivably have not been
identified and are unrecognized.
As you would expect, of course,
there is a relationship between the
number of drugs administered and
the mortality rate and period of
hospitalization, indicating that people who get lots of drugs are generally the sickest.
In studies of pneumonia the rate
of allergic reaction to penicillin
rarely is less than 10% . Yet in patients receiving penicillin in V.D.
clinics, the rate is usually less than
1 % . Is there a relationship between
the presence of infection and the
occurrence of allergic reactions to
drugs? We have shown such a relationship which I think deserves
further study. It's our present supposition that a severe infection may
serve as an adjuvant to an immunological response to a simple
chemical agent.
Over three times more men than
women receiving penicillin in the
hospital will have allergic reactions
to this drug. By history the men in
this study had received penicillin in
the past no more frequently than
women .

Conclusion
I would like to conclude by citing two other rather interesting observations we have made. Threequarters of all the patients in all
our surveillance who have allergic
reactions to drugs have had peptic
ulcer, ulcerative colitis, or neo75
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plastic disease of the gastrointestinal tract. Of these patients, threequarters of the drugs producing
allergic reactions are administered
orally. The rates of allergic reactions to individual drugs in patients
with gastrointestinal disease as opposed to those without gastrointestinal disease receiving the same
medication, are significantly increased. What the impact is of inflammatory gastr,ointestinal disease
1) upon the absorption of the drug,
2) upon its metabolism, and 3)
upon its antigenicity has not been
investigated before. But from these
studies it is suggested that inflammatory disease of the gastrointestinal tract may be an important factor predisposing patients receiving
oral drugs to occurrence of allergic
reactions. It has commonly been
supposed that patients with autoimmunological disorders, e.g., systemic lupus erythematosus, may
have a predisposition to multiple
allergic reactions to drugs. In our
evaluation of this problem, there
is no significant increase in the occurrence of allergic reactions to
drugs in these patients.
I would like to end with some
unresolved questions. We obviously
need more information on rates of
reactions to drugs. Without this the
physician is ill prepared in estimating risk as opposed to benefit. As
Col. Moser pointed out, we can go
20 years before identification of a
possible relationship of thrombocytopenia to tetracycline. It took
six years to identify aplastic anemia
in relation to chloramphenicol.
There must be some better way to
identify the ill effects of drugs than
just by the casual, incidental, periodic reporting in the literature by
physicians who suspect or identify
relationships. I happen to think
this is the greatest value of the
Food and Drug Administration
and the AMA Council on Drugs
Registry on adverse reactions. Unfortunately, however, most of the
reactions reported are those that
we know exist. As far as I am
aware, in the FDA program in op76

eration in a multiplicity of hospitals voluntarily reporting adverse
effects of drugs has not identified a
single previously unrecognized ill
effect of a drug that would not have
been detected as promptly otherwise. We need a great deal more
information about how drugs are
used outside of the hospital by patients who can buy them in the
drug store without prescription. I
was recently amazed when a pharmaceutical representative came into
my office, and I commented about
how many drugs patients kept in
their cabinets at home. The pharmaceutical representative was intrigued and came back the following day having counted the number
of drugs in his cabinet-90! It is
my impression that most of the
patients who developed Fanconi
syndrome from outdated tetracycline were children whose mothers
had been given tetracycline by the
physician, had kept it on the shelf,
and then when the child got ill had
given it to him. I think it's critically
important that the public be informed as much about the problem
of drugs as the medical profession.

We do it poorly. We let journalists
write about how horrible hospitals
are, but I have yet to see anybody
in the medical profession make
any exertion to inform the public
about the use of non-prescription
drugs. We need a great deal more
information about what heritable
factors cause reactions to drugs.
I have indicated some factors
that suggest this may be far
more important than we have previously recognized. We need more
information on other factors-diseases and organ function-which
influence predisposition to drug reactions. Most studies done on the
metabolism, absorption, and excretion of drugs are performed in
normal people. They are not comparable to patients in the hospital
who have fever, renal failure, minor
abnormalities of liver function, who
have respiratory embarrassment
and are in heart failure. We need
a great deal more information
about the reactions to drugs in patients who are sick, as well as we
need increasing information about
the problems of drugs in people
who are well. Thank you.

